Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Biotech Portfolio Updates – Buying More Genentech And Exelixis
Oct 28, 2008 12:12 PM
- When There Is Blood In The Streets - Buy Biotech
Oct 10, 2008 07:37 PM
- Arqule’s Imminent Licensing Deal
Oct 02, 2008 07:39 PM
- Exelixis as a Platform Company
Sep 03, 2008 01:34 AM
- Twenty Stocks to Short Sell
Jul 09, 2008 10:31 AM
- Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration and VIA Pharmaceuticals Set to Join Russell Microcap Index
Jun 27, 2008 10:30 AM
- Monsanto Can Thank Surging Demand And Strong Industry Network For Positive Earnings
Jun 25, 2008 03:47 PM
- Poniard Pharmaceuticals – Platinum Rediscovered (Part II)
Jun 22, 2008 12:30 PM
- Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim and Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia
Jun 16, 2008 08:59 AM
- Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer and Exelixis Announces June 10 Webcast of Presentation at the Goldman Sachs 29th Annual Global Healthcare Conference
Jun 04, 2008 09:29 AM
- Exelixis Announces December 12 Webcast of Its Fourth Annual R&D Day
Nov 24, 2008 04:06 PM
- Exelixis and Bristol-Myers Squibb to Co-Develop XL413, a Selective Cdc7 Inhibitor
Nov 24, 2008 06:06 AM
- Exelixis Announces December 2 Webcast of Presentation at the Piper Jaffray 20th Annual Health Care Conference
Nov 21, 2008 04:16 PM
- Exelixis Announces November 18 Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
Nov 12, 2008 04:31 PM
- Exelixis Research Collaboration With Bristol-Myers Squibb Extended
Nov 06, 2008 06:05 AM
- Exelixis Announces October 30 Webcast of Presentation at the 7th Annual BIO Investor Forum
Oct 28, 2008 10:01 PM
- Exelixis Announces Third Quarter 2008 Financial Results
Oct 27, 2008 04:12 PM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: ECOS, ALGN, ISPH, SIMG, IDTI, EXEL
Oct 27, 2008 09:01 AM
- Exelixis Reports Encouraging Phase 1 Data for XL184 at EORTC-NCI-AACR Symposium
Oct 23, 2008 06:21 AM
- Exelixis Retains Rights to Develop and Commercialize XL184
Oct 23, 2008 06:16 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
EXEL
|
Compare to S&P
|
| YTD |
-60.14 %
|
-0.01 %
|
| 4 Weeks |
1.18 %
|
10.71 %
|
| 12 Weeks |
-45.40 %
|
-22.74 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 9.30 %
|
|
EPS Growth in Last Year: -50.00 %
|
|
Sales Growth in Last Quarter: -1.58 %
|
|
Sales Growth in Last Quarter: 11.58 %
|
|
|
